Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05042414
Other study ID # 263493
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 24, 2021
Est. completion date June 1, 2022

Study information

Verified date October 2022
Source Norwegian University of Science and Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will determine the acute effect of exercise on breastmilk composition. Participants will come in to the lab on three different days, out of which they will exercise on two of these days and rest in the lab on the third day. The conditions will be randomly allocated to each participant. Breastmilk samples will be obtained in the morning of each test day, as well as immediately after, one hour after and four hours after the exercise/rest condition. Dietary intake will be standardized on the test days. At the time of study commencement, the trial (including planned analyses) is not fully funded. Additional milk will be stored for future analyses (not yet specified) when funding is secured.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date June 1, 2022
Est. primary completion date June 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - 6 to 12 weeks postpartum - Exclusive breastfeeding - Term birth Exclusion Criteria: - Known cardiovascular disease - Type 1 or 2 diabetes mellitus - Limited ability to exercise

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
High intensity interval training
Four times four minutes treadmill interval training
Moderate intensity training
Moderate intensity treadmill training
Resting
No training

Locations

Country Name City State
Norway Department of Circulation and Medical Imaging, NTNU Trondheim

Sponsors (2)

Lead Sponsor Collaborator
Norwegian University of Science and Technology St. Olavs Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Other Cardiorespiratory fitness Peak oxygen uptake At baseline
Other Body mass in kg Impedance scale At baseline
Other Height in metres stadiometer At baseline
Other Fat mass in kg Impedance scale At baseline
Other Muscle mass in kg Impedance scale At baseline
Primary Breastmilk metabolite composition Metabolomics profiling Change from before exercise to after exercise (+0 hour, +1 hour, and + 4 hours)
Secondary Adiponectin Concentration in breastmilk Change from before exercise to after exercise (+0 hour, +1 hour, and + 4 hours)
Secondary Leptin Concentration in breastmilk Change from before exercise to after exercise (+0 hour, +1 hour, and + 4 hours)
Secondary Insulin Concentration in breastmilk Change from before exercise to after exercise (+0 hour, +1 hour, and + 4 hours)
Secondary Insulin Growth Factor-1 Concentration in breastmilk Change from before exercise to after exercise (+0 hour, +1 hour, and + 4 hours)
Secondary Cytokine profiling (Multiplex 27) Concentration in breastmilk Change from before exercise to after exercise (+0 hour, +1 hour, and + 4 hours)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04453969 - Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a
Active, not recruiting NCT04453982 - Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b
Active, not recruiting NCT05004740 - Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1c
Recruiting NCT06129266 - Oral Care With Breast Milk in Preterm Newborns Fed by Tube N/A
Recruiting NCT03982732 - Maternal Antibody in Milk After Vaccination